RxSight, Inc.
RXST- Exchange
- Nasdaq
- Industry
- Ophthalmic Goods
- SEC CIK
- 0001111485
In the last 90 days, RxSight, Inc. insiders filed 0 open-market purchases and 4 sales; 151 institutions reported holding it in 13F filings for Q2 2026, worth $199.8M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in RxSight, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 115
- +41 vs. Q1 2023
- Shares held
- 22.1M
- +6.27M (+39.5%) vs. Q1 2023
- Total value
- $637.0M
- +$372.6M (+140.9%) vs. Q1 2023
- New holders
- 48
- 45 more added
- Sold out
- 7
- 13 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RXST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 151 | $199.8M |
| Q1 2026 | 164 | $235.2M |
| Q4 2025 | 164 | $381.8M |
| Q3 2025 | 160 | $298.8M |
| Q2 2025 | 174 | $481.2M |
| Q1 2025 | 192 | $924.1M |
| Q4 2024 | 212 | $1.21B |
| Q3 2024 | 214 | $1.68B |
| Q2 2024 | 228 | $1.98B |
| Q1 2024 | 197 | $1.58B |
| Q4 2023 | 169 | $1.17B |
| Q3 2023 | 128 | $718.1M |
| Q2 2023 | 115 | $637.0M |
| Q1 2023 | 74 | $264.4M |
| Q4 2022 | 58 | $121.6M |
| Q3 2022 | 53 | $109.3M |
| Q2 2022 | 49 | $131.0M |
| Q1 2022 | 45 | $108.3M |
| Q4 2021 | 40 | $75.0M |
| Q3 2021 | 39 | $100.3M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding RxSight, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| State Street Corp | 449,880 | $13.0M | 0.00% | +81,959+22.3% | Added |
| Geode Capital Management, LLC | 451,819 | $13.0M | 0.00% | +52,980+13.3% | Added |
| Driehaus Capital Management LLC | 472,595 | $13.6M | 0.17% | +2,705+0.6% | Added |
| Parkman Healthcare Partners LLC | 498,631 | $14.4M | 2.49% | +70,838+16.6% | Added |
| Atika Capital Management LLC | 514,000 | $14.8M | 1.86% | +514,000 | New |
| JPMorgan Chase & Co | 540,134 | $15.6M | 0.00% | −25,372−4.5% | Reduced |
| Point72 Asset Management, L.P. | 572,443 | $16.5M | 0.06% | +224,275+64.4% | Added |
| Next Century Growth Investors LLC | 833,385 | $24.0M | 2.31% | −43,178−4.9% | Reduced |
| Vanguard Group Inc | 1,178,803 | $33.9M | 0.00% | +159,310+15.6% | Added |
| Millennium Management LLC | 1,233,353 | $35.5M | 0.04% | +550,082+80.5% | Added |
| Lord, Abbett & Co. LLC | 1,431,221 | $41.2M | 0.14% | +1,092,431+322.5% | Added |
| Morgan Stanley | 1,507,075 | $43.4M | 0.00% | +1,451,598+2,616.6% | Added |
| BlackRock Inc. | 1,629,928 | $46.9M | 0.00% | +382,119+30.6% | Added |
| Artisan Partners Limited Partnership | 2,078,470 | $59.9M | 0.10% | −568,171−21.5% | Reduced |
| Ra Capital Management, L.P. | 3,052,796 | $87.9M | 1.66% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −1,202,833−100.0% | Sold out |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −105,250−100.0% | Sold out |
| Bridger Management, LLC | 0 | $0 | 0.00% | −99,100−100.0% | Sold out |
| Magnetar Financial LLC | 0 | $0 | 0.00% | −88,236−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −80,000−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −16,763−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −16,108−100.0% | Sold out |